4 , 5 A full electronic health record might provide more information explaining these differences, and a meta-analysis of previous studies suggests that there may be significant differences in efficacy across these medications. 21 Consistent with previous studies, the average cost per patient over the observation period was lowest in the cohort with the longest duration of monotherapy.
← all excerpts
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs.
1
—
—